Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.19.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities    
Net income (loss) $ 26,503 $ 16,125
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 1,793 2,314
Amortization of deferred financing costs 3,359 5,122
Equity-based compensation 6,989 5,225
Equity method investments 3,874 5,572
Non-cash gain on securitization (8,351) (16,009)
Changes in receivables held-for-sale 0 3,143
Changes in accounts payable and accrued expenses (6,443) (766)
Other (7,234) (6,207)
Net cash provided by (used in) operating activities 20,490 14,519
Cash flows from investing activities    
Equity method investments (30,903) (347)
Equity method investment distributions received 37,558 56,353
Purchases of and investments in receivables (97,280) (3,466)
Principal collections from receivables 36,130 16,912
Proceeds from sales of receivables 96,690 0
Purchases of real estate 0 (15,842)
Purchases of investments (14,916) (6,384)
Principal collections from investments 4,010 682
Proceeds from sales of investments 61,659 0
Funding of escrow accounts (26,340) (21,518)
Withdrawal from escrow accounts 21,790 14,660
Other 1,756 (728)
Net cash provided by (used in) investing activities 90,154 40,322
Cash flows from financing activities    
Proceeds from credit facilities 81,500 32,938
Principal payments on credit facilities (130,501) 0
Proceeds from issuance of non-recourse debt 33,302 46,673
Principal payments on non-recourse debt (103,121) (62,067)
Payments on deferred funding obligations (13,886) (57,039)
Net proceeds of common stock issuances 96,669 15,332
Payments of dividends and distributions (42,073) (35,277)
Other (9,601) (3,447)
Net cash provided by (used in) financing activities (87,711) (62,887)
Increase (decrease) in cash, cash equivalents, and restricted cash 22,933 (8,046)
Cash, cash equivalents, and restricted cash at beginning of period 59,353 118,177
Cash, cash equivalents, and restricted cash at end of period 82,286 110,131
Interest paid 27,973 33,284
Non-cash changes in deferred funding obligations and non-recourse debt (financing activity) (78,172) 1,674
Non-cash changes in receivables and investments (investing activity) 60,143 0
Non-cash changes in residual assets (investing activity) (11,458) (16,883)
Non-cash changes in escrow accounts (investing activity) $ 18,029 $ 0